Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 87 | 2024 | 3233 | 6.890 |
Why?
|
Transplantation Tolerance | 32 | 2024 | 605 | 5.190 |
Why?
|
Graft Rejection | 80 | 2024 | 4438 | 4.470 |
Why?
|
Immune Tolerance | 35 | 2022 | 2300 | 2.800 |
Why?
|
Graft Survival | 58 | 2024 | 3806 | 2.450 |
Why?
|
Transplantation, Homologous | 58 | 2024 | 4808 | 2.260 |
Why?
|
Kidney Transplantation | 35 | 2024 | 4226 | 2.120 |
Why?
|
Swine, Miniature | 46 | 2018 | 961 | 2.010 |
Why?
|
Transplantation Immunology | 10 | 2019 | 532 | 1.980 |
Why?
|
Lung Transplantation | 23 | 2022 | 1308 | 1.940 |
Why?
|
Major Histocompatibility Complex | 17 | 2017 | 927 | 1.630 |
Why?
|
Immunosuppressive Agents | 34 | 2024 | 4168 | 1.570 |
Why?
|
Swine | 57 | 2022 | 5915 | 1.380 |
Why?
|
Lymphocyte Depletion | 10 | 2016 | 602 | 1.200 |
Why?
|
Thymus Gland | 8 | 2015 | 1241 | 1.170 |
Why?
|
Organ Preservation | 8 | 2024 | 379 | 1.160 |
Why?
|
Organ Transplantation | 14 | 2024 | 1154 | 1.140 |
Why?
|
Macaca fascicularis | 17 | 2018 | 901 | 1.140 |
Why?
|
Killer Cells, Natural | 11 | 2014 | 2202 | 1.140 |
Why?
|
Diphtheria Toxin | 9 | 2018 | 252 | 0.990 |
Why?
|
Isoantigens | 12 | 2020 | 552 | 0.950 |
Why?
|
Brain Death | 6 | 2024 | 356 | 0.940 |
Why?
|
T-Lymphocytes, Regulatory | 17 | 2024 | 3072 | 0.940 |
Why?
|
Chimerism | 9 | 2020 | 155 | 0.900 |
Why?
|
Transplantation Chimera | 12 | 2021 | 594 | 0.900 |
Why?
|
Immunity, Innate | 12 | 2024 | 3059 | 0.860 |
Why?
|
Interleukin-2 | 9 | 2024 | 1891 | 0.840 |
Why?
|
Histocompatibility | 6 | 2021 | 317 | 0.780 |
Why?
|
Tissue Donors | 13 | 2024 | 2319 | 0.760 |
Why?
|
Cyclosporine | 10 | 2005 | 778 | 0.700 |
Why?
|
Animals | 140 | 2024 | 168253 | 0.700 |
Why?
|
Heart | 10 | 2022 | 4391 | 0.690 |
Why?
|
Transplantation, Heterologous | 12 | 2022 | 2385 | 0.680 |
Why?
|
Histocompatibility Antigens Class I | 12 | 2009 | 1355 | 0.680 |
Why?
|
Immunotoxins | 6 | 2018 | 175 | 0.660 |
Why?
|
Transplantation | 1 | 2019 | 219 | 0.590 |
Why?
|
Coronary Vessels | 14 | 2021 | 3088 | 0.570 |
Why?
|
Kidney | 11 | 2024 | 7046 | 0.510 |
Why?
|
Perfusion | 5 | 2021 | 1374 | 0.510 |
Why?
|
Coronary Artery Disease | 9 | 2021 | 6388 | 0.490 |
Why?
|
Immunoconjugates | 5 | 2017 | 953 | 0.470 |
Why?
|
Bone Marrow Transplantation | 8 | 2017 | 2693 | 0.450 |
Why?
|
Coronary Disease | 9 | 2009 | 5919 | 0.450 |
Why?
|
Receptors, CCR4 | 4 | 2018 | 77 | 0.440 |
Why?
|
Models, Animal | 13 | 2019 | 2111 | 0.430 |
Why?
|
Interleukin-6 | 2 | 2022 | 3209 | 0.430 |
Why?
|
T-Lymphocytes | 19 | 2020 | 10188 | 0.420 |
Why?
|
Histocompatibility Antigens Class II | 8 | 2008 | 1445 | 0.420 |
Why?
|
Vascular Diseases | 5 | 2014 | 1161 | 0.400 |
Why?
|
Interleukin-15 | 2 | 2012 | 185 | 0.400 |
Why?
|
Interferon-gamma | 9 | 2024 | 3157 | 0.390 |
Why?
|
Skin Transplantation | 10 | 2015 | 1083 | 0.380 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 5 | 2021 | 305 | 0.380 |
Why?
|
Cryopreservation | 2 | 2018 | 725 | 0.370 |
Why?
|
Cardiac Myosins | 1 | 2011 | 128 | 0.360 |
Why?
|
Histocompatibility Testing | 8 | 2015 | 719 | 0.360 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2012 | 280 | 0.340 |
Why?
|
Transplantation Conditioning | 7 | 2017 | 1588 | 0.340 |
Why?
|
Antigens, Differentiation | 3 | 2001 | 910 | 0.330 |
Why?
|
Hematopoietic Stem Cell Mobilization | 2 | 2010 | 225 | 0.330 |
Why?
|
Ischemia | 1 | 2018 | 1876 | 0.330 |
Why?
|
Flow Cytometry | 16 | 2020 | 5865 | 0.320 |
Why?
|
Forkhead Transcription Factors | 6 | 2020 | 1611 | 0.310 |
Why?
|
Sirolimus | 4 | 2022 | 1533 | 0.310 |
Why?
|
Transplants | 2 | 2021 | 206 | 0.310 |
Why?
|
Histocompatibility Antigens | 3 | 2015 | 467 | 0.300 |
Why?
|
Isoantibodies | 8 | 2021 | 674 | 0.300 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2024 | 1766 | 0.290 |
Why?
|
Postoperative Complications | 14 | 2020 | 15627 | 0.280 |
Why?
|
Heart Valve Prosthesis | 6 | 2005 | 1469 | 0.280 |
Why?
|
Lymphocyte Culture Test, Mixed | 5 | 2015 | 516 | 0.270 |
Why?
|
Bioprosthesis | 3 | 2002 | 593 | 0.270 |
Why?
|
Primates | 3 | 2019 | 523 | 0.270 |
Why?
|
Mice, Inbred BALB C | 13 | 2022 | 6206 | 0.270 |
Why?
|
Organ Specificity | 4 | 2021 | 1956 | 0.260 |
Why?
|
Erythropoietin | 2 | 2022 | 719 | 0.260 |
Why?
|
Heart Failure | 9 | 2024 | 11653 | 0.260 |
Why?
|
Complement System Proteins | 4 | 2021 | 788 | 0.260 |
Why?
|
Immunity, Cellular | 5 | 2011 | 1559 | 0.260 |
Why?
|
Coronary Artery Bypass | 7 | 2005 | 2188 | 0.260 |
Why?
|
Tissue and Organ Procurement | 5 | 2024 | 950 | 0.260 |
Why?
|
Adaptive Immunity | 4 | 2021 | 725 | 0.250 |
Why?
|
Myocardium | 8 | 2016 | 4700 | 0.250 |
Why?
|
Antibodies, Monoclonal | 13 | 2016 | 9176 | 0.250 |
Why?
|
CD40 Ligand | 3 | 2022 | 526 | 0.240 |
Why?
|
Chemokines, CXC | 1 | 2006 | 422 | 0.230 |
Why?
|
Abscess | 1 | 2008 | 606 | 0.230 |
Why?
|
Mice | 41 | 2024 | 81402 | 0.230 |
Why?
|
Macrophages | 5 | 2022 | 5764 | 0.230 |
Why?
|
Humans | 103 | 2024 | 760437 | 0.220 |
Why?
|
Mice, Inbred C57BL | 22 | 2023 | 22121 | 0.220 |
Why?
|
Mycophenolic Acid | 1 | 2005 | 347 | 0.220 |
Why?
|
Hypersensitivity, Delayed | 4 | 2011 | 490 | 0.220 |
Why?
|
Endothelin-1 | 2 | 2015 | 302 | 0.220 |
Why?
|
Mice, Inbred DBA | 6 | 2023 | 621 | 0.220 |
Why?
|
Cytotoxicity, Immunologic | 4 | 2015 | 1351 | 0.210 |
Why?
|
Stem Cell Transplantation | 3 | 2013 | 1598 | 0.210 |
Why?
|
Immunologic Memory | 5 | 2019 | 1359 | 0.210 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2024 | 4575 | 0.210 |
Why?
|
Endothelium, Vascular | 4 | 2007 | 4430 | 0.210 |
Why?
|
Autoantibodies | 1 | 2011 | 2123 | 0.200 |
Why?
|
Drug Costs | 1 | 2010 | 1179 | 0.200 |
Why?
|
Aortic Diseases | 1 | 2008 | 737 | 0.200 |
Why?
|
Coronary Stenosis | 1 | 2008 | 794 | 0.200 |
Why?
|
Cytokines | 3 | 2022 | 7377 | 0.190 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 1989 | 899 | 0.190 |
Why?
|
Tunica Intima | 4 | 2007 | 459 | 0.190 |
Why?
|
Proteus Infections | 1 | 2000 | 10 | 0.190 |
Why?
|
Proteus vulgaris | 1 | 2000 | 8 | 0.190 |
Why?
|
Recombinant Fusion Proteins | 6 | 2018 | 3734 | 0.190 |
Why?
|
Radiation Tolerance | 1 | 2003 | 479 | 0.190 |
Why?
|
Heart Diseases | 3 | 2020 | 2785 | 0.180 |
Why?
|
Aortic Valve | 6 | 2005 | 1960 | 0.180 |
Why?
|
Thymectomy | 4 | 2006 | 194 | 0.180 |
Why?
|
Mediastinitis | 1 | 2000 | 49 | 0.180 |
Why?
|
Glomerular Filtration Rate | 3 | 2024 | 2171 | 0.180 |
Why?
|
Coronary Circulation | 2 | 2005 | 1565 | 0.180 |
Why?
|
Receptors, Erythropoietin | 2 | 2019 | 144 | 0.180 |
Why?
|
Stromal Cells | 1 | 2006 | 1330 | 0.180 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2000 | 57 | 0.180 |
Why?
|
Blood Transfusion | 3 | 2005 | 1299 | 0.180 |
Why?
|
Antigens, Heterophile | 1 | 2000 | 70 | 0.170 |
Why?
|
Expert Testimony | 1 | 2022 | 361 | 0.170 |
Why?
|
Multiple Organ Failure | 1 | 2002 | 386 | 0.170 |
Why?
|
Time Factors | 22 | 2024 | 39947 | 0.170 |
Why?
|
Antibodies, Blocking | 1 | 2000 | 243 | 0.170 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 616 | 0.170 |
Why?
|
Acute Disease | 7 | 2011 | 7230 | 0.160 |
Why?
|
Myocardial Ischemia | 3 | 2006 | 2110 | 0.160 |
Why?
|
Immunization | 5 | 2011 | 1226 | 0.160 |
Why?
|
Blood Vessels | 1 | 2005 | 1113 | 0.160 |
Why?
|
Neovascularization, Physiologic | 1 | 2006 | 1339 | 0.160 |
Why?
|
Medication Adherence | 1 | 2010 | 2166 | 0.160 |
Why?
|
Adenosine Triphosphate | 2 | 2015 | 1989 | 0.160 |
Why?
|
Hematopoiesis | 2 | 2015 | 2049 | 0.150 |
Why?
|
Immune System | 2 | 2021 | 794 | 0.150 |
Why?
|
Ventricular Septal Rupture | 1 | 1998 | 17 | 0.150 |
Why?
|
Organ Preservation Solutions | 2 | 2018 | 100 | 0.150 |
Why?
|
Donor Selection | 1 | 2020 | 230 | 0.150 |
Why?
|
Blood Vessel Prosthesis | 2 | 2000 | 954 | 0.150 |
Why?
|
Genes, MHC Class I | 2 | 1989 | 240 | 0.150 |
Why?
|
Nephritis, Interstitial | 1 | 2019 | 155 | 0.150 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 462 | 0.150 |
Why?
|
Complement C4b | 2 | 2010 | 132 | 0.150 |
Why?
|
Immunoglobulin M | 3 | 2016 | 1530 | 0.140 |
Why?
|
Primary Graft Dysfunction | 1 | 2018 | 111 | 0.140 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5835 | 0.140 |
Why?
|
Receptor Cross-Talk | 1 | 2017 | 116 | 0.140 |
Why?
|
Transplantation, Heterotopic | 2 | 1996 | 174 | 0.140 |
Why?
|
Photoreceptor Cells | 4 | 1984 | 236 | 0.140 |
Why?
|
Kidney Diseases | 2 | 2020 | 2093 | 0.140 |
Why?
|
Tacrolimus | 4 | 2015 | 733 | 0.130 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 964 | 0.130 |
Why?
|
Immediate-Early Proteins | 1 | 2019 | 449 | 0.130 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2005 | 1554 | 0.130 |
Why?
|
Mice, Inbred C3H | 8 | 2020 | 915 | 0.130 |
Why?
|
Glycosuria | 1 | 2015 | 44 | 0.130 |
Why?
|
Lymphocytes | 2 | 2003 | 2610 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2019 | 3800 | 0.130 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2019 | 793 | 0.130 |
Why?
|
Ketosis | 1 | 2015 | 46 | 0.130 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2015 | 321 | 0.130 |
Why?
|
Lupus Nephritis | 1 | 2019 | 317 | 0.130 |
Why?
|
Mitral Valve | 3 | 2005 | 1471 | 0.120 |
Why?
|
Amyloidosis | 2 | 2013 | 817 | 0.120 |
Why?
|
Prosthesis-Related Infections | 1 | 2000 | 488 | 0.120 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 212 | 0.120 |
Why?
|
HLA Antigens | 4 | 2021 | 1371 | 0.120 |
Why?
|
Reperfusion Injury | 1 | 2021 | 1023 | 0.120 |
Why?
|
Hemodynamics | 2 | 2022 | 4167 | 0.120 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2016 | 357 | 0.120 |
Why?
|
Antigen Presentation | 1 | 2020 | 1254 | 0.120 |
Why?
|
Antigens, CD19 | 1 | 2017 | 425 | 0.110 |
Why?
|
Neointima | 1 | 2014 | 133 | 0.110 |
Why?
|
Mannitol | 1 | 2014 | 180 | 0.110 |
Why?
|
Disaccharides | 1 | 2014 | 170 | 0.110 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2000 | 696 | 0.110 |
Why?
|
Peptides | 2 | 2007 | 4338 | 0.110 |
Why?
|
Lung Diseases | 3 | 2015 | 1909 | 0.110 |
Why?
|
Histidine | 1 | 2014 | 308 | 0.110 |
Why?
|
Electrolytes | 1 | 2014 | 274 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2012 | 4369 | 0.110 |
Why?
|
Pulsatile Flow | 1 | 2014 | 321 | 0.110 |
Why?
|
Interleukin-10 | 4 | 2012 | 1176 | 0.110 |
Why?
|
Chimera | 1 | 2014 | 453 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 2 | 2001 | 1805 | 0.110 |
Why?
|
Glutamates | 1 | 2014 | 389 | 0.110 |
Why?
|
Disease Models, Animal | 9 | 2020 | 18216 | 0.110 |
Why?
|
Sus scrofa | 1 | 2014 | 428 | 0.110 |
Why?
|
Male | 46 | 2024 | 360035 | 0.110 |
Why?
|
B-Lymphocytes | 4 | 2019 | 4748 | 0.100 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 696 | 0.100 |
Why?
|
Th17 Cells | 1 | 2019 | 792 | 0.100 |
Why?
|
Kidney Function Tests | 3 | 2024 | 675 | 0.100 |
Why?
|
Ventricular Function, Left | 2 | 2016 | 3876 | 0.100 |
Why?
|
Apoptosis | 4 | 2015 | 9468 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1925 | 0.100 |
Why?
|
Liver Transplantation | 2 | 2014 | 2332 | 0.100 |
Why?
|
Glutathione | 1 | 2014 | 582 | 0.100 |
Why?
|
Lymphocyte Activation | 4 | 2012 | 5491 | 0.100 |
Why?
|
Pichia | 3 | 2017 | 49 | 0.100 |
Why?
|
Bioartificial Organs | 1 | 2011 | 47 | 0.100 |
Why?
|
Chronic Disease | 10 | 2011 | 9309 | 0.090 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2011 | 57 | 0.090 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2012 | 303 | 0.090 |
Why?
|
Epoetin Alfa | 2 | 2022 | 78 | 0.090 |
Why?
|
Gastroesophageal Reflux | 2 | 2008 | 816 | 0.090 |
Why?
|
Rats, Inbred Lew | 2 | 2006 | 1155 | 0.090 |
Why?
|
Aortic Valve Insufficiency | 3 | 2005 | 579 | 0.090 |
Why?
|
Cold Temperature | 1 | 2014 | 786 | 0.090 |
Why?
|
Transfection | 2 | 1989 | 5776 | 0.090 |
Why?
|
Dendritic Cells | 2 | 2020 | 2725 | 0.090 |
Why?
|
Endarteritis | 1 | 2010 | 5 | 0.090 |
Why?
|
Lung | 6 | 2019 | 9973 | 0.090 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2011 | 293 | 0.090 |
Why?
|
Aorta | 3 | 2008 | 2042 | 0.090 |
Why?
|
Animals, Inbred Strains | 3 | 2003 | 13 | 0.090 |
Why?
|
Treatment Outcome | 13 | 2024 | 64591 | 0.090 |
Why?
|
Embolism, Cholesterol | 1 | 2009 | 32 | 0.080 |
Why?
|
Arenaviridae Infections | 1 | 2009 | 53 | 0.080 |
Why?
|
Stem Cell Factor | 1 | 2010 | 195 | 0.080 |
Why?
|
Hepatitis C | 1 | 2020 | 1583 | 0.080 |
Why?
|
Cardiopulmonary Bypass | 2 | 2009 | 1094 | 0.080 |
Why?
|
Nanoparticles | 1 | 2021 | 1953 | 0.080 |
Why?
|
Membrane Glycoproteins | 1 | 2000 | 3701 | 0.080 |
Why?
|
Peptide Fragments | 3 | 2010 | 5105 | 0.080 |
Why?
|
Melphalan | 1 | 2010 | 420 | 0.080 |
Why?
|
Cell Proliferation | 6 | 2015 | 10425 | 0.080 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2009 | 178 | 0.080 |
Why?
|
Amino Acid Sequence | 5 | 2015 | 13445 | 0.080 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 409 | 0.080 |
Why?
|
Tracheostomy | 1 | 1992 | 426 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2015 | 1317 | 0.080 |
Why?
|
Kidney Failure, Chronic | 2 | 2024 | 2462 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 4 | 2009 | 3629 | 0.080 |
Why?
|
Leukapheresis | 2 | 2010 | 134 | 0.080 |
Why?
|
Reoperation | 7 | 2009 | 4300 | 0.070 |
Why?
|
Genes, MHC Class II | 1 | 1989 | 451 | 0.070 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2010 | 348 | 0.070 |
Why?
|
Carrageenan | 1 | 2007 | 71 | 0.070 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 222 | 0.070 |
Why?
|
Rats | 7 | 2011 | 23712 | 0.070 |
Why?
|
H-2 Antigens | 1 | 1988 | 358 | 0.070 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 17639 | 0.070 |
Why?
|
Cells, Cultured | 6 | 2019 | 18955 | 0.070 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2010 | 629 | 0.070 |
Why?
|
Toll-Like Receptors | 1 | 2010 | 589 | 0.070 |
Why?
|
Leukocytes | 1 | 2015 | 2024 | 0.070 |
Why?
|
Immunotherapy | 2 | 2021 | 4649 | 0.070 |
Why?
|
Vision, Ocular | 3 | 1979 | 454 | 0.070 |
Why?
|
Form Perception | 3 | 1984 | 175 | 0.070 |
Why?
|
Immunoglobulin G | 4 | 2006 | 4549 | 0.070 |
Why?
|
Antigens, Ly | 1 | 1987 | 294 | 0.070 |
Why?
|
Complement C4 | 1 | 2007 | 244 | 0.070 |
Why?
|
Arteries | 2 | 2010 | 1125 | 0.070 |
Why?
|
Antigens, CD | 3 | 2001 | 4000 | 0.060 |
Why?
|
Mitral Valve Insufficiency | 2 | 2005 | 1404 | 0.060 |
Why?
|
Aortic Aneurysm | 2 | 2009 | 648 | 0.060 |
Why?
|
Debridement | 1 | 2008 | 493 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2014 | 1666 | 0.060 |
Why?
|
Endothelium | 1 | 2008 | 765 | 0.060 |
Why?
|
Heart Valve Diseases | 2 | 2004 | 1037 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6297 | 0.060 |
Why?
|
Oxygen Consumption | 1 | 2011 | 1859 | 0.060 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2016 | 2117 | 0.060 |
Why?
|
Self Tolerance | 1 | 2005 | 123 | 0.060 |
Why?
|
Stem Cells | 2 | 2015 | 3522 | 0.060 |
Why?
|
Biopsy | 3 | 2012 | 6765 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2021 | 7849 | 0.060 |
Why?
|
Immunocompromised Host | 1 | 2009 | 855 | 0.060 |
Why?
|
Bronchiolitis Obliterans | 2 | 2008 | 213 | 0.060 |
Why?
|
Adult | 17 | 2024 | 220781 | 0.060 |
Why?
|
Chemokine CXCL12 | 1 | 2006 | 454 | 0.060 |
Why?
|
Female | 26 | 2024 | 391875 | 0.060 |
Why?
|
Adaptation, Physiological | 3 | 2007 | 1301 | 0.060 |
Why?
|
Adaptation, Ocular | 1 | 1984 | 89 | 0.060 |
Why?
|
Adoptive Transfer | 2 | 2020 | 819 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2015 | 5663 | 0.060 |
Why?
|
Color Perception | 3 | 1980 | 212 | 0.060 |
Why?
|
Follow-Up Studies | 8 | 2024 | 39078 | 0.060 |
Why?
|
Middle Aged | 17 | 2024 | 220382 | 0.060 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2002 | 223 | 0.050 |
Why?
|
Forecasting | 3 | 2004 | 2925 | 0.050 |
Why?
|
Galactosyltransferases | 1 | 2005 | 276 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 2 | 2024 | 1841 | 0.050 |
Why?
|
Cell Communication | 2 | 2020 | 1652 | 0.050 |
Why?
|
Heart-Assist Devices | 1 | 2014 | 1286 | 0.050 |
Why?
|
Prognosis | 4 | 2024 | 29551 | 0.050 |
Why?
|
Survival Rate | 5 | 2020 | 12698 | 0.050 |
Why?
|
Coculture Techniques | 2 | 2011 | 1340 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2010 | 1534 | 0.050 |
Why?
|
Homozygote | 2 | 2006 | 1794 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2014 | 6525 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2017 | 1824 | 0.050 |
Why?
|
Oxygen | 1 | 2014 | 4222 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 3076 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2006 | 891 | 0.050 |
Why?
|
Gadolinium | 1 | 2007 | 960 | 0.050 |
Why?
|
Risk Factors | 10 | 2024 | 74055 | 0.050 |
Why?
|
Renal Replacement Therapy | 1 | 2024 | 281 | 0.050 |
Why?
|
Guinea Pigs | 1 | 2004 | 1317 | 0.050 |
Why?
|
Molecular Probes | 1 | 2004 | 310 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11900 | 0.050 |
Why?
|
Papio | 1 | 2004 | 669 | 0.050 |
Why?
|
Pulmonary Artery | 2 | 2022 | 1938 | 0.050 |
Why?
|
Echocardiography | 3 | 2016 | 4981 | 0.050 |
Why?
|
Mice, SCID | 2 | 2017 | 2625 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13616 | 0.050 |
Why?
|
Surgical Wound Infection | 2 | 2002 | 1525 | 0.050 |
Why?
|
Endothelial Cells | 2 | 2021 | 3541 | 0.050 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11070 | 0.050 |
Why?
|
Phagocytosis | 1 | 2007 | 1536 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2013 | 1957 | 0.050 |
Why?
|
Antibodies | 1 | 2010 | 2421 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2024 | 14397 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2024 | 80430 | 0.050 |
Why?
|
Pattern Recognition, Visual | 2 | 1984 | 813 | 0.050 |
Why?
|
Whole-Body Irradiation | 2 | 2014 | 433 | 0.050 |
Why?
|
Pulmonary Circulation | 1 | 2004 | 743 | 0.050 |
Why?
|
Body Constitution | 1 | 2001 | 273 | 0.050 |
Why?
|
Blood Glucose | 1 | 2015 | 6380 | 0.050 |
Why?
|
Insulin | 1 | 2015 | 6591 | 0.050 |
Why?
|
STAT5 Transcription Factor | 1 | 2021 | 264 | 0.040 |
Why?
|
Antilymphocyte Serum | 2 | 2015 | 483 | 0.040 |
Why?
|
Interphase | 1 | 2001 | 228 | 0.040 |
Why?
|
Respiratory Mucosa | 1 | 2004 | 439 | 0.040 |
Why?
|
Povidone-Iodine | 1 | 2000 | 55 | 0.040 |
Why?
|
Leukocyte Transfusion | 1 | 2000 | 56 | 0.040 |
Why?
|
Endarterectomy, Carotid | 1 | 2005 | 555 | 0.040 |
Why?
|
Cricetinae | 1 | 2004 | 2427 | 0.040 |
Why?
|
Protein Kinases | 1 | 2007 | 1607 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3710 | 0.040 |
Why?
|
Endocarditis | 2 | 2001 | 350 | 0.040 |
Why?
|
Aristolochic Acids | 1 | 2019 | 11 | 0.040 |
Why?
|
Fibrosis | 1 | 2007 | 2048 | 0.040 |
Why?
|
Clonal Anergy | 1 | 2000 | 171 | 0.040 |
Why?
|
Breeding | 1 | 1999 | 51 | 0.040 |
Why?
|
Therapeutic Irrigation | 1 | 2000 | 292 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2017 | 10759 | 0.040 |
Why?
|
Base Sequence | 3 | 2015 | 12449 | 0.040 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2019 | 153 | 0.040 |
Why?
|
Pennsylvania | 1 | 2020 | 613 | 0.040 |
Why?
|
Tissue and Organ Harvesting | 1 | 2002 | 373 | 0.040 |
Why?
|
Death | 1 | 2023 | 676 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2019 | 127 | 0.040 |
Why?
|
Antibodies, Heterophile | 1 | 1998 | 128 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2002 | 8522 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11453 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2007 | 2453 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7531 | 0.040 |
Why?
|
Aged | 14 | 2024 | 168840 | 0.040 |
Why?
|
Autoimmunity | 2 | 2008 | 1355 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 1992 | 2891 | 0.040 |
Why?
|
Vimentin | 1 | 2019 | 255 | 0.040 |
Why?
|
Species Specificity | 2 | 2004 | 2417 | 0.040 |
Why?
|
Receptors, Interleukin | 1 | 2019 | 243 | 0.040 |
Why?
|
Models, Biological | 3 | 2007 | 9462 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 29831 | 0.040 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3685 | 0.040 |
Why?
|
Transplantation, Autologous | 2 | 2015 | 2113 | 0.040 |
Why?
|
Antibody Specificity | 2 | 1997 | 1060 | 0.040 |
Why?
|
Phosphorylation | 3 | 2019 | 8311 | 0.040 |
Why?
|
Prosthesis Failure | 2 | 2005 | 1203 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2019 | 9533 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5815 | 0.040 |
Why?
|
Veins | 1 | 2002 | 767 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2021 | 697 | 0.040 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2017 | 36 | 0.040 |
Why?
|
Pulmonary Ventilation | 1 | 2019 | 372 | 0.040 |
Why?
|
Haplotypes | 1 | 2004 | 2773 | 0.040 |
Why?
|
Hormones | 1 | 2021 | 867 | 0.040 |
Why?
|
Myosins | 1 | 2019 | 405 | 0.040 |
Why?
|
Graft vs Host Disease | 2 | 2012 | 3028 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2022 | 823 | 0.040 |
Why?
|
Heart Valves | 1 | 1999 | 284 | 0.040 |
Why?
|
Equipment Design | 2 | 2019 | 3510 | 0.040 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2001 | 825 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2021 | 2265 | 0.030 |
Why?
|
Regression Analysis | 2 | 2013 | 6340 | 0.030 |
Why?
|
Actuarial Analysis | 3 | 2005 | 374 | 0.030 |
Why?
|
Prospective Studies | 5 | 2024 | 54339 | 0.030 |
Why?
|
Inflammation | 3 | 2022 | 10746 | 0.030 |
Why?
|
Child | 3 | 2015 | 80086 | 0.030 |
Why?
|
Heart Neoplasms | 1 | 1999 | 362 | 0.030 |
Why?
|
Survival Analysis | 4 | 2018 | 10075 | 0.030 |
Why?
|
Body Mass Index | 1 | 2013 | 12932 | 0.030 |
Why?
|
Protein Binding | 3 | 2014 | 9340 | 0.030 |
Why?
|
Recurrence | 1 | 2008 | 8466 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 1999 | 422 | 0.030 |
Why?
|
Renal Insufficiency | 2 | 1998 | 809 | 0.030 |
Why?
|
Age Factors | 3 | 2014 | 18379 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 1997 | 778 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2021 | 1492 | 0.030 |
Why?
|
Cross Reactions | 1 | 2016 | 818 | 0.030 |
Why?
|
Visual Pathways | 1 | 1979 | 542 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1790 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 2007 | 1759 | 0.030 |
Why?
|
United States | 2 | 2020 | 72202 | 0.030 |
Why?
|
Horses | 1 | 2015 | 300 | 0.030 |
Why?
|
Cardiac Tamponade | 1 | 1995 | 175 | 0.030 |
Why?
|
Myosin Heavy Chains | 1 | 2016 | 404 | 0.030 |
Why?
|
Cell Separation | 1 | 2020 | 1720 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9410 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5790 | 0.030 |
Why?
|
Endocarditis, Bacterial | 1 | 1998 | 444 | 0.030 |
Why?
|
Plasma Cells | 1 | 2017 | 599 | 0.030 |
Why?
|
Phenotype | 1 | 2012 | 16585 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 678 | 0.030 |
Why?
|
Organ Size | 1 | 1999 | 2252 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 225 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2137 | 0.030 |
Why?
|
Sensory Thresholds | 4 | 1984 | 377 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 1998 | 58859 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21322 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2572 | 0.030 |
Why?
|
Suture Techniques | 1 | 1998 | 771 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2019 | 3486 | 0.030 |
Why?
|
Anastomosis, Surgical | 2 | 1996 | 983 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2019 | 907 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2004 | 5236 | 0.030 |
Why?
|
Thoracic Injuries | 1 | 1995 | 288 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2014 | 1141 | 0.030 |
Why?
|
DNA | 2 | 2017 | 7208 | 0.030 |
Why?
|
Cell Line | 2 | 2014 | 15598 | 0.020 |
Why?
|
Rats, Nude | 1 | 2011 | 105 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2000 | 1669 | 0.020 |
Why?
|
Radiation Chimera | 1 | 2011 | 216 | 0.020 |
Why?
|
H-Y Antigen | 1 | 2011 | 42 | 0.020 |
Why?
|
Mice, Congenic | 1 | 2011 | 97 | 0.020 |
Why?
|
Lung Compliance | 1 | 2011 | 200 | 0.020 |
Why?
|
Registries | 2 | 2020 | 8216 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1887 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3469 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 1998 | 1272 | 0.020 |
Why?
|
Ribs | 1 | 1992 | 252 | 0.020 |
Why?
|
Troponin T | 1 | 2016 | 763 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2501 | 0.020 |
Why?
|
Cause of Death | 2 | 1998 | 3686 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2011 | 379 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3108 | 0.020 |
Why?
|
Blood Group Incompatibility | 1 | 2011 | 136 | 0.020 |
Why?
|
Clavicle | 1 | 1992 | 224 | 0.020 |
Why?
|
Patient Selection | 1 | 2022 | 4240 | 0.020 |
Why?
|
Aortic Valve Stenosis | 1 | 2002 | 2008 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 16945 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6128 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2011 | 794 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 417 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 1995 | 807 | 0.020 |
Why?
|
Waiting Lists | 1 | 2013 | 765 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3590 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 410 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2014 | 982 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2014 | 1438 | 0.020 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 263 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2642 | 0.020 |
Why?
|
Splenectomy | 1 | 2010 | 391 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 1989 | 436 | 0.020 |
Why?
|
Rheology | 1 | 2009 | 348 | 0.020 |
Why?
|
Interleukin-1 | 1 | 2012 | 1250 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3624 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 22083 | 0.020 |
Why?
|
Alanine | 1 | 2010 | 606 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 1996 | 1494 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 1998 | 12054 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2000 | 3396 | 0.020 |
Why?
|
Skin | 1 | 2001 | 4474 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2010 | 539 | 0.020 |
Why?
|
Length of Stay | 2 | 1998 | 6413 | 0.020 |
Why?
|
Signal Transduction | 3 | 2021 | 23397 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3066 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 1998 | 1580 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9605 | 0.020 |
Why?
|
Immunization, Passive | 1 | 1989 | 616 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1751 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5031 | 0.020 |
Why?
|
ABO Blood-Group System | 1 | 2009 | 380 | 0.020 |
Why?
|
Gastrostomy | 1 | 2008 | 322 | 0.020 |
Why?
|
Disease Progression | 2 | 2016 | 13484 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2008 | 472 | 0.020 |
Why?
|
Materials Testing | 1 | 2009 | 864 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2023 | 11526 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2009 | 1370 | 0.020 |
Why?
|
Muromonab-CD3 | 1 | 2005 | 104 | 0.020 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2010 | 738 | 0.020 |
Why?
|
beta Catenin | 1 | 2010 | 1040 | 0.020 |
Why?
|
History, Ancient | 1 | 2005 | 212 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 2296 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4567 | 0.010 |
Why?
|
Rats, Inbred WF | 1 | 2004 | 138 | 0.010 |
Why?
|
Sex Factors | 1 | 1998 | 10538 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12429 | 0.010 |
Why?
|
Perceptual Masking | 1 | 1984 | 90 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1346 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1649 | 0.010 |
Why?
|
International Cooperation | 1 | 2010 | 1428 | 0.010 |
Why?
|
Spectrophotometry | 1 | 1984 | 310 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3421 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6471 | 0.010 |
Why?
|
Coloring Agents | 1 | 2005 | 559 | 0.010 |
Why?
|
Discrimination Learning | 1 | 1984 | 278 | 0.010 |
Why?
|
Risk Assessment | 1 | 2004 | 23953 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 1992 | 1646 | 0.010 |
Why?
|
Capillaries | 1 | 2005 | 755 | 0.010 |
Why?
|
Minor Histocompatibility Loci | 1 | 2001 | 16 | 0.010 |
Why?
|
Hospitalization | 2 | 1998 | 10698 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 2002 | 2090 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2005 | 2468 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15820 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3445 | 0.010 |
Why?
|
Motion Perception | 1 | 1984 | 373 | 0.010 |
Why?
|
Surgical Wound Dehiscence | 1 | 2002 | 213 | 0.010 |
Why?
|
Hospital Mortality | 3 | 2001 | 5283 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4355 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8163 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2413 | 0.010 |
Why?
|
Nephrectomy | 1 | 2005 | 934 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 2005 | 1681 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2004 | 3075 | 0.010 |
Why?
|
Hypersensitivity | 1 | 2007 | 1157 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2010 | 2247 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2007 | 2058 | 0.010 |
Why?
|
Societies, Medical | 1 | 2010 | 3904 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15257 | 0.010 |
Why?
|
Gene Deletion | 1 | 2005 | 2667 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12785 | 0.010 |
Why?
|
Stroke Volume | 1 | 2010 | 5487 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4287 | 0.010 |
Why?
|
Methods | 1 | 1996 | 1074 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1999 | 2560 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27060 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1999 | 1832 | 0.010 |
Why?
|
Motion | 1 | 1978 | 780 | 0.010 |
Why?
|
Multiple Trauma | 1 | 1995 | 369 | 0.010 |
Why?
|
Photic Stimulation | 1 | 1979 | 1971 | 0.010 |
Why?
|
Genotype | 1 | 2006 | 12976 | 0.010 |
Why?
|
Carotid Artery Diseases | 1 | 1997 | 872 | 0.010 |
Why?
|
Action Potentials | 1 | 1978 | 1830 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 59068 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1997 | 1475 | 0.010 |
Why?
|
Accidents, Traffic | 1 | 1995 | 816 | 0.010 |
Why?
|
Attitude to Health | 1 | 1997 | 2025 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 36362 | 0.000 |
Why?
|
Epitopes | 1 | 1992 | 2504 | 0.000 |
Why?
|
Patient Satisfaction | 1 | 1997 | 3457 | 0.000 |
Why?
|
Boston | 1 | 1997 | 9326 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1997 | 3596 | 0.000 |
Why?
|
Psychophysics | 1 | 1984 | 289 | 0.000 |
Why?
|
Stroke | 1 | 2004 | 9745 | 0.000 |
Why?
|
Visual Perception | 1 | 1980 | 1379 | 0.000 |
Why?
|